News

Take a look of our latest news

Pharmazac launched the first Rosuvastatin generic in the Greek Pharmaceutical Market. Rosuvastatin is available in two forms of 14 and 30 film coated tablets and composition of 5mg, 10mg, 20mg and 40mg. Rosuvastain/Pharmazac is an HMG – CoA reductase inhibitor indicated for patients with primary hypercholesterolaemia or mixed...

Pharmazac has released the new product Nitastin 20mg film coated tablet for treatment of heart disease In addition to the hypolipidemic actions Nitastin has beneficial effects in endothelial dysfunction, on the vascular wall, the state of atheroma, improves blood rheology, have antioxidant, antiproliferative properties. There is evidence that...